Amryt Pharma Share Discussion Threads

[2vdm] 14/11/2017 11:44

Probably because TW in Hot Stock Rockets has updated as a sell this a.m.

[waterloo01] 14/11/2017 11:30

Looking rather weak and suspect some 20% stop loses triggered. I've added a few as I don't think (but don't know) if it's anything fundamental (ie Lox sales or AP101). House broker retains it's speculative 65p target based on Lox alone.

[greendragon777] 14/11/2017 11:22

This is the time to grab your balls gentlemen....absolutely no point in bailing out now. We're nearly at the price level that it wouldn't even matter if we get AP101 approval in terms of the price going lower!

Hold or forever hold your peace! 😁

[pottermagic2310] 14/11/2017 10:47

See below (1059 - April of this year)....


pottermagic2310
25 Apr '17 - 12:20 - 1059 of 1838 0 0 Edit

Main risks, which should be obvious, are:

-that the Trial fails to secure the target Patients needed to the constrained timescales the Trial needs to be conducted to - Trial fails, no Product, no future

- that the Trial fails to benefit target Patients in the ways hoped for, to the constrained timescales the Trial must operate over - Trial fails, no Product, no future

There is a 50:50 probability of a successful/failed outcome in both scenarios.
The proximity is 1st quarter 2018 to 3rd quarter 2018.
The Business Plan's 'golden goose' could be 'scrambled egg' by September 2018 or April 2018, depending on Trial outcomes.

You stand to gain a lot from September 2018 onwards if the Trial proceeds well.
You stand to lose the lot by September 2018 if the Trial fails in 1 or more ways.

I'm invested and have very little to lose (currently) and everything to gain (possibly). DYOR

[volsung] 14/11/2017 10:07

Well sold the other half today. GLA

[papillon] 13/11/2017 16:53

Well, greendragon, there was no need for us to rush into buying AMYT shares because unless there is an unexpectedly good news RNS(s) issued in what remains of 2017 we could have waited until the start of 2018 before investing. We could be snoozing for what remains of 2017. LOL.

[greendragon777] 13/11/2017 14:48

Good to see they are teeing up the markets for AP101 too.....shows a bit of confidence for it's approval etc. If I had some spare cash I would be averaging down now big time.....still happy with my position though!

Oh, it's nearly 3pm already.....time for another snooze! :-)

[papillon] 13/11/2017 14:37

Underwhelming share price reaction to today's underwhelming RNS! Back to sleep and back to a declining sp!

[papillon] 10/11/2017 23:53

Obviously not, Punter6.

[punter6] 09/11/2017 11:41

Anyone meet Joe Wiley yesterday?...!!

[greendragon777] 09/11/2017 11:20

Thanks for the article Paps, interesting read. $300m effectively evaporated into thin air! 🙈

Yes ETH had a big run up along with a few other Alt coins. IOTA has jumped 50% in the last couple of days!. As people are beginning to shift money back into the alts from BTC.

[papillon] 08/11/2017 20:11

O/T. FAO, greendragon.

"Ethereum has rapidly become the second most important cryptocurrency, after Bitcoin, with its price increasing more than 2,500% over the past year. One token of Ether is now worth a little over $285, up from $8 in January."

That's some rise! Beats an investment in AMYT shares in January hands down! LOL

[papillon] 08/11/2017 11:21

WOW! Do my eyes deceive me, or do we have a rise in the AMYT sp? Miracles do happen! LOL.

[greendragon777] 08/11/2017 00:01

Haha....maybe they could throw in a board meeting while they're there and at least make some use of the time! 😁

[papillon] 07/11/2017 23:00

Nobody going then? Could it be that Joe Wiley & Rory Nealon will be the only ones present at this AMYT presentation? LOL.

[papillon] 07/11/2017 17:02

bigwavedave 26 Oct '17 - 12:39 - 1802 of 1826 0 0
KTZ Communications hereby cordially invite you to meet Joe Wiley, CEO, and Rory Nealon, CFO & COO, of Amryt Pharma (AIM: AMYT, ESM: AYP), the rare and orphan diseases specialist, on Wednesday, 8 November 2017.
The presentation, followed by a Q&A session, will take place at 12.30pm at the offices of KTZ Communications, No.1 Cornhill, London, EC3V 3ND.
Amryt key facts:
• Strategy is to acquire, develop and commercialise medicines to treat patients with rare and orphan diseases.
• There are c7,000 identified rare diseases, but less than 10% have approved treatments.
• Existing, revenue-generating product, Lojuxta – used to treat the rare genetic cholesterol disorder, HoFH; total est. market size €100m (Europe & MENA); H1 17 sales €5.75m.
• Lead candidate, AP101 – potential treatment for the devastating skin disorder, Epidermolysis Bullosa; currently in Phase III clinical trials, interim data expected in H1 18; total est. market size €1.3bn+.
• Earlier stage asset, AP102 – potential treatment for Acromegaly and Cushing’s Disease; expected to complete pre-clinical development by end of 2017; total est. market size€900m+ (€500m+ Acromegaly, €400m+ Cushing’s Disease).
• An extremely experienced management team with >100 years of experience in healthcare and the pharmaceutical industry.
• Board chaired by Shire Pharmaceuticals̵7; founder, CEO and Chairman, Harry Stratford OBE.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

The 8th is tomorrow. Anyone going? Will it have any positive effect on the sp? I somehow doubt it, but would love to be proved wrong!

[volsung] 07/11/2017 16:41

Pricilla Queen of the Desert pingpong?

[papillon] 07/11/2017 16:34

Ping pong balls in good condition definitely bounce high when dropped, but damaged ones hardly bounce at all, greendragon! Lets hope the AMYT ping pong ball is in good condition in 2018! Fingers crossed. LOL.

I can't predict the future, greendragon, but lets hope the recent sellers of AMYT shares, below 20p, are shown to be mugs, hopefully in what remains of 2017.

[greendragon777] 07/11/2017 16:19

Success is how high you bounce when yet hit the ground......AMYT is gonna bounce like a ping pong ball in 2018! 😁

[papillon] 07/11/2017 14:01

I sincerely hope that 2018 is AMYT's year, greendragon, as 2017 (so far) definitely hasn't been! LOL.

[greendragon777] 07/11/2017 12:04

Haha....seems to be holding up so far Paps but that could change of course. 2018 will be our year and anyone who dumped their positions before then will be sat there kicking themselves as John Virgo would say when commenting on a snooker player! :-)

[papillon] 06/11/2017 17:02

Sod me! The share price didn't go down today. No doubt normality will resume tomorrow! LOL.

[papillon] 04/11/2017 20:17

Bronxville
Posts: 6
Off Topic
Opinion: No Opinion
Price: 19.00
Congemi..Fri 10:28 You're the only one who called this right.Are you still holding?Whats your opinion now?
This board has gone dead..

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Congemi has sold his AMYT shares going by his post of the 21st September:

AMYT Bought in a 22.4 a few week ago 21 Sep '17
When I talked to Rory Nealon he said to me he coukd understand why the share valuation was so low considering their phase 3 trial..So why dilute the company by 25%?
Aim stock exchange Crooks!

Will be selling all my shares in the next couple of days.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

In fact Congemi's last post on any of the lse bb's was on the 23rd September so it looks like he was true to his word and sold all of his AMYT shares. A wise move, with the benefit of hindsight!!

PS. The recent placing @20p was, apparently, the final straw for Congemi. Obviously he's wrong with his "Crooks" comment. The AMYT BoD are not "Crooks". Opportunists, more like! They've taken the opportunity of fully funding the company now instead of waiting until after the interim AP101 trial update scheduled for next year. Why? It could be they have another licensing deal lined up, or it could be that they are not prepared to take the risk of a poor AP101 interim trial update just before tapping up the market for more money? After all a bird in the hand is worth two in the bush!

[papillon] 01/11/2017 23:20

"Down, Down". Could be the AMRYT anthem! LOL.